-We wanted to vaccinate the children severely affected by their egg allergy with the same vaccine thatas the rest of the Nnorwegian population got, , was receiving at the time, and that vaccine contained egg residue.
Ethical aspects
We obtained the written consent of the parents of the case histories presented in this article.
We did not obtain approval for the study from the Regional Committee for
Research Ethics in Northernin Northern Norway before commencing the vaccination drive, but we applied for approval in November 2010. The Committee responded that it considered the vaccination drive as 'part of ordinary treatment', even though it could have been experimental, and that the project therefore fell outside its mandate. However, it added that we as the applicants had the right to 'publish the treatment'. (3, 4, 5) warned against vaccinating patients with severe egg allergy withthat it should not be used in patients with severe egg allergy. 3, 4, 5 the availableinfluenza vaccine, . The available monovalent Influenza A H1N1 vaccine Pandemrix from Glaxo Smith Kline (GSK). This vaccine contained egg-protein (Ovalbuminovalbumin) residue. It was said that there would be aAn egg-free vaccine was expected, but would not be available ,.
hHowever, the first doses of this vaccine were not available in Norway before the first week of December 2009December 2009 (6) and then only in a very limited number of doses. 6 It wasAn NHA appointed advisory group recommended (7) that patients with egg allergy should be examined by a physician with a special competence in allergies and that. pPatients with anaphylactic shock reactions to egg should not get the vaccinebe vaccinated at all. 7 In addition, it was recommended that patients who exhibit , those with a severe reaction to egg should be subjected to have a skin prick test to determine , and then decide whether or not the individual should could be safely vaccinated. The advisory group regarded one or more of the following reactions as a A severe reaction to egg as severe: was regarded as one of the following reactions, urticaria, angioedema, airway oedema, asthma, urticaria ,urticaria, rhinitis or vomiting.
The pediatric outpatient clinic at the University Hospital North Norway hassees about 6000 consultations per year, and approximately half of these consultations concerning atopic diseases. In an article from October 2009 (8) , it was recommended to use a two-arm approach when vaccinating patients allergic to egg with influenza vaccine containing less than 1.2 microgram/ml Ovalbuminovalbumin.In October 2009 Erlewyn-Lajeunesse et al.
recommended that patients allergic to egg should receive only vaccines containing <1.2 µg/ml ovalbumin, and that a two-dose split protocol should be used in individuals with severe egg allergy. 8 According to the producer, of the vaccine (GSK), Pandemrix available monovalent Influenza A H1N1 vaccine contained less than 0.33366 microgram/ml Ovalbuminovalbumin (9). <0.333 µg/ml ovalbumin. 9 We wanteddecided to vaccinate the children and adolescents allergic to egg with the recommendations from the article (8) .by Erlewynn-Lajeunesse et al. 8 All the patients able to eat food containing even only the slightest amount of egg should receive the vaccine at the community centre and not at the hospital. Only patients unable to digest the slightest amount of egg, including egg-containing baked goods , without a reaction were vaccinated at the outpatient clinic. We vaccinated 81 children and adolescents. The only patients to be vaccinated at the outpatient clinic were those unable to digest the slightest amount of egg, including egg-containing baked goods. Originally the recommendation from the NHA was to get two doses of the vaccinewas that the patients should receive two doses of the vaccine. H, however before we could vaccinate administer the second timedose, new information from the NHA became available in December 2009 (10), indicating, indicating that one dose of the vaccine produced a sufficient the immune response was sufficient with one vaccine dose.
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The objective of this study was to determine the safety of administringadministering a monovalent Influenza A H1N1 vaccine to egg allergic patients following the guidelines in the article.
The Regional Committee for research ethics had no objections to this study.
Material and Method and material

Setting
The vaccination drive took place at the outpatient clinic of the Department of Pediatrics at the University Hospital of North Norway in Tromsø, Norway.
Vaccinations were administered from 4 November to 1 December 2009.
Study participants A total of 80 children were vaccinated: 50 (62.5%) boys and 30 (37.5%) girls. Mean age was six years and three months. Some of the patients were under our care while others had been referred to us for vaccination by their general practitioner.
Criteria for inclusion in the study There were two criteriatwo criteria and both had to be met. The first criterion was a diagnosed sensitisation to egg demonstrated by a positive skin prick test (SPT) or positive serum analysis for specific IgE-(SSIgE-) mediated egg allergy. The SPT was considered positive if a wheal of more than 3 mm formed; the SSIgE was analysed with either the Siemens Immulite® or® or the Phadia ImmunoCAP®. The second criterion was that the patient had to be on an egg-free diet and be unable to eat any food containing any amount of egg, including eggcontaining baked goods, without an allergic reaction to egg protein. We also included patients who were sensitised to egg but had never been exposedbeen exposed to egg or egg-containingegg containing baked goods and were on an egg-free diet.
Concurrent atopic diseases
We recorded other atopic diseases in the included patients only if they were on current medication for asthma, allergy or eczema or if they were on a diet that avoided food other than egg. The other atopic diseases had been diagnosed by a physician prior to vaccination.
No other diseases than atopic diseases were recorded.
Course of action An appointment was made for all patients at the outpatient clinic. Every day, one nurse was assigned to administer the vaccine. The same physician (BF) conducted all interviews, examinations and evaluations for all patients, and decided whether they should receive a fractionated or a singledose vaccine. All patients were interviewed and physically examined. A form that contained written instructionswritten instructions on which type of vaccination the patient should receive, was completed. Included on the form was the dosage of intramuscular adrenaline, intravenous hydrocortisone and oral antihistamine to be administered in case of a severe allergic reaction.
The vaccinations took place from November 4 to December 1 2009. There were 50 (62,5%) boys and 301 (37,58%) girls. Mean age 6 years 36 months. The patients were partly under our care, and partly referred to us for vaccination from their general practitioner. There were two inclusion criteria, and both had to be met. The first criterion was a diagnosed allergy sensitation to egg, with a positive skin prick test (SPT), or positive serum analysis for specific IgE (SSIgE) mediated egg allergy. The SPT was considered positive with a wheal more than 3 mm, the SSIgE was analyzed with either Immulite from Siemens, or Immunocap from Phadia (11), values over 0.35 kU/L were considered positive. The second criterion was staying on an egg free diet, unable to eat any food containing any amount of egg, including egg-containing baked goods, without an allergic reaction to egg protein. We also included patients sensitized to egg but never being exposed to egg or egg-containing baked goods that were on an egg free diet. We registered patients with other atopic diseases in the included patients only if they they were on current medication for asthma, allergy, eczema, or on a food avoiding diet other than egg. The other atopic diseases had been diagnosed by a physician prior to vaccination. No other diseases than atopic diseases was registered.
All patients received an appointment at the outpatient clinic. One nurse was assigned every day to do the vaccination. The same physician (BF) did all the interviews, examinations and evaluations for all patients, and decided whether they should get the vaccine fractioned or not. All patients had an interview and a physical examination. A form was filled out with a written ordination of which vaccination the patient should receive. Included on the form was the dosage of i.m. adrenaline, i.v. hydrocortisone and p.o. anti-histamine in case of a severe allergic reaction.
All the patients could be vaccinated, allAll the asthmatics on the programme were in a stable phase of their asthma.and all patients could be vaccinated.
Two of the children had a very severe atopic eczema at the time of vaccination;. oOne of them was an inpatient because of theas a result of severe eczema. Any reaction occurring while the patients were at the outpatient clinic was registered by the nurse and examined by the same doctor that had done the initial assessment.If any reaction to the vaccine occurred while a patient was at the outpatient clinic, it would be recorded by the nurse and the patient would be examined by the same doctor who had conducted the initial assessment. Every reaction except sorenesspain at the injection site was registeredrecorded.
No new blood samples were taken for diagnosing allergy, as we relied on the available information. This is the same approach that has to be taken if a mass vaccination has to take place.We adopted the approach advised in the case of mass vaccination and took no new blood samples for the purpose of diagnosing allergy, relying on the available information.
Dose and administration
The vaccine dose of vaccine was age dependent, 0.25 ml for those under 10 years of age, and 0.5 ml for those over 10 years.
The enrolled patients were divided into two groups as described by M Erlewyn-Lajenuesse et alin the article (8) . The groups got either a fractioned dose of vaccine with first 1/10 dose and after 30 minutes the remaining 9/10 of the dose. by Erlewyn-Lajeunesse et al. 8 One group was given fractionated doses of the vaccine: first a tenth and after 30 minutes the remaining nine-tenths of the dose. The other group got the vaccine as a single dose.
The other group got the vaccine as a single dose. The criteriona for getting the fractioned dose were, prior anaphylaxis, cardiovascular complications or collapse. This includes respiratory symptoms, hypotension and circulatory shock and severe abdominal pain, when exposed to egg proteinwhich determined whether a patient should receive the fractionated dose, which determined whether a patient should receive the fractionated dose, was that he or she must have suffered from prior anaphylaxis, cardiovascular complications or collapse when exposed to egg protein. This included respiratory symptoms, hypotension, circulatory shock and severe abdominal pain.
The criteriona for the single dose was mild gastrointestinal and dermatological reactions, including urticaria, angioedema and vomiting, when exposed to egg protein which determined whether a patient should receive the single dose was that he or she should have suffered from mild gastrointestinal and dermatological reactions when exposed to egg protein, including urticaria, angioedema and vomiting.
One of the recommendations in the article was not followed. known allergy to egg, but without ever being who had never been exposed to egg in any form should get the vaccine as a single dose at the hospital.
Because the reaction of these patients to egg was unknown it was decided to vaccinate these patientsthem with a fractionateded dose.
The patients waited 30 minutes between the fractionated doses, and 60 minutes after the final fractionated dose. The patients who received receiving a single dose waited 30 minutes before they left the clinic. The patients and parents were encouraged to give us feedback if there was a delayed allergic reaction after they got home.provide us with feedback should a patient experience a delayed allergic reaction after returning home.
All patients and parents were informed that vaccinating patients with egg allergy with this vaccine was discouraged by the NHA, but there were reason to believe that they still could be vaccinated, and some articles published indicated the same (8, 12) . They were also informed that the vaccination was done at the outpatient clinic in case of a reaction. Both patients and parents expressed their confidence in the treatment and information they were given.All patients and parents were informed that the NHA had discouraged using this particular vaccine in individuals with egg allergy, but that there was reason to believe they could still be vaccinated, and that some published articles agreed. 8. They were also informed that the vaccine was administered at the outpatient clinic in case of an adverse reaction. Both patients and parents expressed their confidence in the treatment and information they were given.
Statistical analysis
We used Wilcoxon Rank Sum test, en ……,,Chi, Chi square and Student ttest to test for statistical significance. A, a p-value <0,05 was considered significant.
Results
Study population A total of 801 (100%)patients (50 boys and 301 girls) were enrolled, and all of them gotand were all vaccinated. Mean age was 6,25.5 years, ranging from 10 months to 22.2 16,5years. The oldest patient in this study was a mother who came to get her daughter vaccinated, and ended up being vaccinated herself. Mean age of those getting the vaccine fractioned was 6 years 9 months, and those getting single dose vaccine were 6 years 3 months. Table 1 shows the number of vaccinated patients according to age, fractioning of vaccine dose , previous exposure to egg and concurring atopic diseases. The criterion for serious allergic reaction to egg were prior anaphylaxis, cardiovascular complications or collaps. This includes respiratory symptoms, hypotension and circulatory shock, and severe abdominal pain, when exposed to egg or egg-containing baked goods. Never exposed to egg means that the parents stated that the kids had never been exposed to egg or egg-containing baked goods. The criteria for mild allergic reaction to egg were prior mild gastrointestinal and dermatological reactions, including urticaria, angioedema and vomiting, when exposed to egg or egg-containing baked goods. Food allergy means diagnosed food allergy besides egg allergy. SSIgE means serum spesific IgE to egg protein.
The criterion for serious allergic reaction to egg was that the patient must have suffered from prior anaphylaxis, cardiovascular complications or collapse. This includes respiratory symptoms, hypotension and circulatory shock, and severe abdominal pain when exposed to egg or egg-containing baked goods.
· Never exposed to egg means the parents stated that the kids had never been exposed to egg or egg-containing baked goods. · The criteria for mild allergic reaction to egg were prior mild gastrointestinal and dermatological reactions, including urticaria, angioedema and vomiting when exposed to egg or egg-containing baked goods.
· Food allergy refers to a diagnosed food allergy apart from egg allergy. · SSIgE refers to serum-spesific IgE to egg protein. Of the 801 patients, 389 (48%) got the vaccine fractioned were given the fractionated dose and 42 (52%) received the vaccine as a single dose. There is a statistical difference in age between the patients never being exposed to egg, and those having a severe allergic reaction to egg. The groups weregroups were indistinguishable with regard to SSIgEto SSIgE level and time since the SSIgE level had been done. There was also no difference in the median and the range of SSIgE between the two groups. SSIgE had been measured between one month and 10 years before, with a mean time 28.6time 28.6 months. Half of the patients who had their SSIgE measured were older than one year, and the SSIgE had a median value of 25.4 kU/L.
The groups of patients receiving the vaccine fractioned or as one dose were indistinguishable regarding age, SSIgE level, and time since the SSIgE level was done. BToth the median and the range of SSIgE shows no differences between the groups receiving the vaccine fractioned or not. The range for when the SSIgE was done was one month to ten years, the mean time for when the SSIgE was taken was 28,6 months. Half of the SSIgE was older than 1 year, and the median value of those were 25,4 kU/l.
A surprisingly high number of patients -19 (243%) -had according to their parents, never been exposed to egg. These patients had for some reason been tested for egg allergy,. tThe tests had shown elevated SSIgE to levels against egg protein, and they had consequently they had avoided egg thereafter. The testing had happened took place before they had had a chancean opportunity to be exposed to egg. At our clinic, patients with suspicious allergies to other foods or a severe atopic eczema will routinely be tested for food allergies, including egg allergy.
A high number of patients -634 (79%) -had other atopic diseases other than those caused by egg allergy and 39 (49%) patients were on treatment for asthma. A total of 38 (48%) patients suffered from ongoing eczema.
than food allergy to egg and 3940 (49%) patients were treated for asthma.
There was a slight difference between the two groups regarding other atopic disease in addition to egg allergy as 32 (82%) of the patients getting fractioned dose and 30 (71%) of those getting single dose had other atopic diseases, asthma being the main difference.
A total of 38 (48%) patients had an ongoing eczema. There were 43 (54%) patients with other allergies besidesapart from egg allergy, that includinges both food and inhalation allergies. All in all, these 43 patients suffered from a total of 134 recorded allergies. Food allergies were the most common (32 (40%) patients), while 24 (30%) of the patients presented with an inhalation allergy.
There were registered 134 allergies among the 43 patients. Food allergies were the most common with 32 (40%) patients, 24 (301%) of the patients presented with an inhalation allergy. There were are no statistical significant differences between the three groups never being exposed to egg, a severe allergy to egg or a mild allergy to egg, getting fractioned or single dose vaccine regarding atopy, asthma, food allergies besides egg allergy, inhalation allergies or eczema,atopy, asthma, food allergies other than egg allergy, inhalation allergies or eczema. food or inhalation allergy.
Description of reactionsResponses to the vaccine
Despite that the patients and their parents were encouraged to contact the outpatient clinic after the vaccination if a delayed allergic reaction occurred;
nobody reported any problems after being vaccinated.
All patients and their parents were encouraged to contact the outpatient clinic after the vaccination if a delayed allergic reaction occurred, but nobody reported any such reaction. and food allergies (milk, fish), was given a fractionated dose and started to sneeze after the second dose. There were no cardiovascular symptoms and pulmonary auscultation also showed no bronchoconstriction. The sneezing was self-limiting and happens regularly at home, according to the parents.
Patient D (16 years old)
This reaction took the longest to resolve, but the symptoms were eventually attributed to fear of being exposed to an eggcontaining vaccine as the patient had previously had an anaphylactic reaction to egg-containing food. The patient had also been diagnosed with asthma and had an SSIgE >99 kU/L, measured in the month before vaccination. The patient had been anxious before coming to the clinic and had skipped breakfast. The patient experienced abdominal pain after the first fractionated dose, and had to lie down and was repeatedly examined, and the conclusion was that there was no allergic reaction. The vaccine was further fractionated four times and the last administration was six-tenths of the dose. Total time spent at the outpatient clinic was three hours, but the patient felt fit when leaving. The method used to vaccinate this patient (extended fractionating) is similar to the extended-fractionating method described in the AAP Committee on Infectious Disease's Red Book. 13 We decided on multiple fractionating for this patient because the psychological symptoms could have masqueraded as allergic reactions. By administering the vaccine in very small steps, the patient felt reassured that there would be no severe allergic reaction. Without such reassurance the vaccination might have become so uncomfortable for the patient that it could have become impossible to complete.
After this incident all the teenagers were asked if they had had breakfast and those who did not had to eat before being vaccinated.
Four patients had symptoms shortly after the vaccination. The first patient had a confirmed mild allergic reaction to the vaccine. The two other patients had symptoms that perhaps could be related to a reaction against the vaccine. The fourth patient had symptoms due to fear of being exposed to a vaccine containing egg. The three first patients had never been exposed to egg, and the fourth patient had experienced anaphylactic reaction eating food containing egg. All of four patients got a fractioned vaccine, and all had an SSIgE taken within the last month before vaccination, except for the 8 year old who had a 3 year old SSIgE.
The patient with the mild reaction was a 2 years and 8 months, asthma, food allergies (milk, fish, peas, peanuts), SSIgE 1.7 kU/L and never been exposed to egg. Few minutes after the second dose there was a wheal of one centimetre on the left lower side of the lip, a self-limiting rash down the thighs, and also one loose stool. No cardiovascular or respiratory involvement. The patient got an oral antihistamine, but that was mostly because of a long travel home by car, and left the clinic one hour after the second dose.
Two patients had possible reactions to the vaccine.
One 11 months old with severe ongoing eczema, and multiple food allergy (milk, wheat, barley, oats, rye, fish, peanuts) SSIgE > 99kU/L, had never been exposed to egg. The right ear was more erythematous, and a slight swelling around the eye on the same side after the second dose. This reaction was difficult to distinguish from the rest of his eczema symptoms that varies a lot.
No cardiovascular or respiratory involvement. The other patient was 8 years and 7 month old and had asthma, inhalation allergy (grass-pollen) and food allergies (milk, fish). SSIgE 14.6 kU/L, and had never exposed to egg. The patient started to sneeze after the second dose. There were no cardiovascular involvement and no bronco-constriction when pulmonary auscultation was done. The sneezing was self-limiting, and something that happens on a regular basis at home, according to the parents.
The reaction that took the longest time to resolve was a 16 year old, patient with asthma, SSIgE >99 kU/L. There had been an earlier anaphylactic shock to egg, the patient had been anxious before coming to the clinic, and had skipped breakfast. The patient experienced abdominal pain after the first fractioned dose. The patient had to lie down, was repeatedly examined, with the conclusion of no allergic reaction. The vaccine is further fractioned 4 times, last dose was 6/10 of the dose. Total time spent at the outpatient clinic is 3 hours, but the patient felt well when leaving the outpatient clinic. The method used to get this patient vaccinated is more similar to the method described in RED Book (13) with an extended fractioning of the dose. The reason to vaccinate this patient with a multiple fractioning of the dose was psychological symptoms disguising as allergic reactions. By taking it stepwise in very small steps, the patient felt assured that there would be no severe allergic reaction. If the patient had not been assured in this way, it would have been uncomfortable for the patient, to the degree that it would have been impossible to complete the vaccination.
After this incident all the teenagers were asked if they had eaten breakfast and those who had not, had to eat before getting vaccinated.
Discussion and conclusions
Injecting a person with the intent of vaccination also brings the potential of an adverse reaction. In this study there was one adverse reaction, and two possible adverse reactions.Of the patients who participated in this study, one showed a clear adverse reaction to the egg-containing vaccine and two had a possible adverse reaction. All of the reactions were mild and needed , with no need for immediate intervention. Because they had an egg allergy, all the patients in the group were considered at high risk ,risk, even more so because 79% of them suffered from other atopic diseases as well.
The group being vaccinated in this study was considered a high-risk group because of their egg allergy, and even more so when 79% of the patients had other atopic diseases besides egg allergy. The approach taken in this study
shows it is possible to vaccinate egg allergic patients, even those with anaphylaxis to egg and concurring atopic disease, with a regular influenzavaccine, that has less than 0.333 mikrogram/ml66 mg/ml
Ovalbuminovalbumin content.
The findings of C. Kelly and V. Gangur that there is a sex disparity in food allergic children under 18 years of age (14) , which males predominates, correlates well with our study group where 63% of the patients under 18 are males.Safety of vaccination in patients allergic to egg The study confirmed that patients allergic to egg can be safely vaccinated with a regular influenza vaccine containing < 0.333 µg/ml ovalbumin, even if these patients had displayed previous anaphylactic reactions to egg and had been diagnosed with concurrent atopic diseases. Patients getting the vaccine fractioned had a higher prevalence of asthma, than the ones getting the vaccine as a single dose. Asthma in patients with food allergy increases the risk of anaphylaxis.
(15) Respiratory involvement was also one of the inclusion criterions for getting the vaccine fractioned, this can explain the difference in asthma prevalence between the patients getting the vaccine fractioned or as a single dose.By following the guidelines in the article, we were able to vaccinate the patients allergic to egg. 8 If future influenza vaccines were to contain considerably larger amount of ovalbumin, we would consider to useusing the same guidelines as in this study. 14 The increased risk is 29.4% for asthma, 27.2% for eczema and 31.5% for inhalation allergies. Our study population had a higher prevalence of all these atopic diseases (asthma 49%, eczema 48%, inhalation allergy 30%, other food allergy 40%) -in other words, they were more affected by atopic disease than is to be expected, even in individuals allergic to egg.
Significance of concurrent atopic diseases
The NCHS data brief from 2008 (14.) showed that patients with food allergy under the age of 18 years had an increased risk of other atopic diseases, asthma 29,4 %, eczema 27,2% and inhalation allergies 31,5%. Our study population had higher prevalence for all of these atopic diseases (asthma 49%, eczema 48%, inhalation allergy 30%, other food allergy 40%).
demonstrating that our study population is a selected group more affected by atopic disease than is to be expected, even among those allergic to egg.
The other studies that have looked at the safety of vaccinating with vaccine containing egg residue, has not looked into the aspect of concurring other atopic diseases. (15, 16, 17, 12) Concurring atopic diseases is of concern when vaccinating, but we have showed that even though our study population were more affected than expected with concurring atopic disease, they could still be vaccinated.
Other studies investigating the safety of vaccinating with products that contain egg residue have not considered the aspect of other concurrent atopic diseases. 15, 16, 17, 12 Concurrent atopic diseases are of concern in vaccination, but we showed that even though our study population was affected more heavily than one would expect, these patients could still be safely vaccinated.
The one patient with a definite reaction to the vaccine, and the two with possible reactions to vaccine had never been exposed to egg. This may warrant for a cautious approach when vaccinating anyone tested positive for egg allergy, but never have been exposed to egg. These patients should be treated as if they had had severe reactions to egg exposure when vaccinating with a vaccine containing egg residue.
Significance of no previous exposure to egg The patient with an allergic reaction to the vaccine and the two patients with possible reactions had never before been exposed to egg. This could indicate that a cautious approach is needed in the vaccination of individuals who had tested positive for egg allergy but had never been exposed to egg. When immunised with and eggcontaining vaccine, these patients should be treated as if they had in fact exhibited a reaction to egg exposure.
Significance of SSIgE/SPT PractitionersSPT Practitioners treating patients
with food allergies should be aware that the level of SSIgE or size of SPT does not predict the severity of a food reaction. 18 The patients in our study who were given the fractionated-dose vaccine had displayed the most severe allergic reactions to egg. Yet we found no difference in SSIgE levels of those who received the fractionated dose and those who received the vaccine as a single dose. This finding emphasisesemphasizes that SSIgE levels should not determine whether the vaccine should be fractionated or not.
Significance of age There was a significant age difference between the patients who had never been exposed to egg, and those with a severe reaction to egg. We believe the reason for this is that it is difficult to keep children on an egg free diet. The moment they are exposed to egg, they are relegated to put in one of the two other groups, with a known allergic reaction to egg.
When handling patients with food allergies, one must be aware that the level of SSIgE or size of SPT does not predict the severity of a food reaction. (1820) The patients in our study getting the vaccine fractioned have the most severe allergic reactions to egg. Yet we find no difference in SSIgE levels between the ones getting the vaccine fractioned or as a single dose. This finding emphasize that the level of SSIgE should not determine whether the vaccine should be fractioned or not.
Dose fractionation
In this study we chose to vaccinate either with a fractionated or a single dose. All patients tolerated the 10% dose, and ultimately received the 90% dose, and only one patient showed a mild reaction. This indicates that in the case of a vaccine with an ovalbumin level of <0.333 µg/ml, all patients could in fact have received the vaccine as a single dose without serious complications.
Risk of overestimating allergic reactions Every centre administering
vaccines knows the protocols that should be followed in the event of an allergic reaction to a vaccine. When patients with prior anaphylactic reactions to egg are vaccinated, it is important that the centre administering the vaccine also has experience of allergies. If not, allergic reactions could be overestimated as a result of misinterpretation of symptoms, as could have been the case with patient D in our study.
In this study we chose to vaccinate either with a fractioned dose or a single dose. All the patients tolerated the 10% dose, and ultimately received the 90% dose with only one mild reaction. This shows that we could have given all the patients the vaccine as a single dose when the ovalbumin level is <0,333 mikrogram/ml. This study shows that also patients with prior serious allergic reactions to egg can be vaccinated using a fractioned vaccine approach. Every centre giving vaccines are educated for the task in an event of an allergic reaction to the vaccine. When vaccinating patients with prior anaphylactic reactions to egg, it is important that the centre given the vaccine also have experience with allergies. If not there will be an overestimation of allergic reactions, as demonstrated by the fourth patient in our study.
The approach that were taken in this study can be used when there is a need for mass vaccination, A simple questionnaire can replace the interview, 
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